OMERS Administration Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

OMERS Administration Corp’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-765	Closed	-$213K	–	940
2026 Q1	$213K	Hold	765	–	–	﹤0.01%	907
2025 Q4	$232K	Hold	765	–	–	﹤0.01%	880
2025 Q3	$214K	Buy	+765	New	+$208K	﹤0.01%	965
2025 Q1	–	Sell	-890	Closed	-$292K	–	1035
2024 Q4	$292K	Buy	890 +138	+18%	+$46.8K	﹤0.01%	822
2024 Q3	$252K	Hold	752	–	–	﹤0.01%	771
2024 Q2	$205K	Buy	+752	New	+$219K	﹤0.01%	883
2019 Q2	–	Sell	-8,900	Closed	-$2.82M	–	394
2019 Q1	$2.82M	Buy	+8,900	New	+$2.4M	0.03%	121
2015 Q2	–	Sell	-11,700	Closed	-$1.58M	–	428
2015 Q1	$1.58M	Buy	+11,700	New	+$1.45M	0.06%	169

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OMERS Administration Corp's BIO Position: Q2 2026 in Review

OMERS Administration Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 765 shares — an estimated $213K sold.

OMERS Administration Corp first reported a position in BIO in Q1 2015 and held it in 8 quarters. The position peaked at $2.82M in Q1 2019. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

OMERS Administration Corp reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
OMERS Administration Corp sold 765 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $213K.
OMERS Administration Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 8 quarters.
OMERS Administration Corp's Bio-Rad Laboratories Class A position peaked at $2.82M in Q1 2019.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.